MorphoSys Research Site

Brussels 1090

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-cell Lymphoma, Non-Hodgkin Lymphoma

Studies at this site

• Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed DLBCL — Completed
• Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat Non-Hodgkin's Lymphoma (NHL) — Completed